Table 5.
The relationship between the diagnostic rates of lung cancer by sniffer dog using BT and lung cancer stage or tumor mass.
| Sample | Lung Cancer Stage | Location | Dog A | Dog B | Dog C | Dog D | Dog E | Dog F |
|---|---|---|---|---|---|---|---|---|
| 33 BT | Adenocarcinoma (IIIB) | RUL | 100% | 91.7% | 91.7% | 100% | 100% | 91.7% |
| 41 BT | Adenocarcinoma (IA) | LUL | 100% | 91.7% | 77.1% | 83.3% | 100% | 66.7% |
| 42 BT | Squamous cell carcinoma (IA) | LUL | 100% | 80.0% | 80.0% | 86.7% | 80.0% | 53.3% |
| 43 BT | Adenocarcinoma (IIIA) | RUL | 100% | 75.0% | 83.3% | 58.3% | 83.3 | 58.3% |
| 44 BT | Adenocarcinoma (IA) | LUL | 100% | 100% | 83.3% | 75.0% | 100% | 66.7% |
| 45 BT | Adenocarcinoma (IA) | LLL | 100% | 87.5% | 91.7% | 83.3% | 92.7% | 93.8% |
| 46 BT | Adenocarcinoma (IIA) | LUL | 100% | 86.7% | 86.7% | 80.0% | 80.0% | 80.0% |
| 47 BT | Adenocarcinoma (IA) | RLL | 86.7% | 86.7% | 66.7% | 40.0% | 13.3% | 46.7% |
| 48 BT | Adenocarcinoma (IA) | LLL | 86.7% | 80% | 80.0% | 86.7% | 86.7% | 86.7% |
| 49 BT | Adenocarcinoma (IA) | RUL | 100% | 93.3% | 86.7% | 86.7% | 93.3% | 66.7% |
| 50 BT | Adenocarcinoma (IIIB) | LUL | 100% | 66.7% | 93.3% | 93.3% | 86.7% | 73.3% |
Breathing Target (BT): exhaled breathing samples collected from the patients with confirmed diagnosis of lung cancer. RUL: right upper lobe; RML: right middle lobe; RLL: right lower lobe, LUL: left upper lobe; LLL: left lower lobe.